Home › Biotech Deserves A Piece Of Every Dividend Growth Portfolio
 

Keywords :   


Biotech Deserves A Piece Of Every Dividend Growth Portfolio

2016-01-26 07:14:29| Biotech - Topix.net

Taking into account their projected EPS growth rates and potential for dividend growth, both companies, but in particular Gilead Sciences, are attractively valued relative to the market. Amgen became a pioneer in the biotech world when it became the first large biotech stock to begin paying a regular dividend in 2011.

Tags: growth piece portfolio biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Farm Progress America, May 15, 2024
15.05ACCESS and Neusoft offer integrated in-vehicle solution
15.05Livepeer Studio cuts the cost of live streaming & transcoding
15.05More subscribers choose streaming with ads in Sweden
15.05Five more San Antonio TV stations launch NEXTGEN TV
15.05Liberty Latin America organic Video RGUs up 2,000 in 1Q 2024
15.05Dine and dash couple hit my pizzeria, says owner
15.05Boeing may face criminal prosecution, US says
More »